Koyfin Home > Directory > Health Care > Biogen Inc > Cash and Short-Term Investments

Biogen Inc Cash and Short-Term Investments Chart (BIIB)

Biogen Inc annual/quarterly Cash and Short-Term Investments from 2010 to 2020.
  • Biogen Inc Cash and Short-Term Investments for the quarter ending June 06, 2020 was $4,328m a -2.54% decrease of -110m year over year
  • Biogen Inc Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $4,328m a -2.54% decrease of -110m year over year
  • Biogen Inc Annual Cash and Short-Term Investments for 2019 was $4,476m a 20.95% increase of 938m from 2018
  • Biogen Inc Annual Cash and Short-Term Investments for 2018 was $3,538m a -4.27% decrease of -151m from 2017
  • Biogen Inc Annual Cash and Short-Term Investments for 2017 was $3,689m a -32.69% decrease of -1,206m from 2016
Other Balance Sheet Metrics:
  • Biogen Inc Total Assets for the quarter ending December 12, 2018 was $25,289m a -3.17% decrease of -801m year over year
  • Biogen Inc Other Liabilities for the quarter ending December 12, 2018 was $3,026m a 1.80% increase of 55m year over year
  • Biogen Inc Total Equity for the quarter ending December 12, 2018 was $13,032m a -7.72% decrease of -1,006m year over year
View Chart On Koyfin

Quarterly BIIB Cash and Short-Term Investments Data

06/2020$4,328m
03/2020$3,860m
12/2019$4,476m
09/2019$4,437m
06/2019$3,116m
03/2019$3,909m
12/2018$3,538m
09/2018$4,428m
06/2018$3,224m
03/2018$5,916m

Annual BIIB Cash and Short-Term Investments Data

2019$4,476m
2018$3,538m
2017$3,689m
2016$4,895m
2015$3,429m
2014$1,845m
2013$1,223m
2012$1,706m
2011$1,691m
2010$1,208m